COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis

Autor(es)

Faria, M. S. M. S. ; Shinjo, S. K.

• Tipo de documento: Artigo Científico
• Fonte: REUMATISMO; v. 74, n. 1, p. 3-pg., 2022-01-01.

Resumo

Borges et al. have recently reported the first case of a dermatomyositis onset in close association with established coronavirus disease 2019 (COVID-19). Similarly, we report a patient who, on the contrary, had COVID-19 following early established dermatomyositis. We report prospectively the outcome of her disease. (AU)

• Processo FAPESP: 19/11776-6 - Impacto e segurança da neuromodulação cerebral não-invasiva em pacientes com doenças autoimunes sistêmicas: estudo duplo cego, randomizado e placebo-controlado
• Beneficiário: Samuel Katsuyuki Shinjo
• Modalidade de apoio: Auxílio à Pesquisa - Regular